This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Advancing today’s therapies to enable healthier lives
We are focused on transforming patient care by enhancing existing therapeutic medicines to bring safer, more effective and convenient treatments to patients
Arecor Proprietary Pipeline
Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions
Tetris Pharma Portfolio
Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe
Our Partners
We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development
Latest News and Events
-
7th September 2023
ARECOR ANNOUNCES POSITIVE PRE-IND MEETING WITH FDA FOR NOVEL READY-TO-USE MEDICINE AT307 LICENSED TO HIKMA
-
4th September 2023
TETRIS PHARMA ANNOUNCES COMMERCIALISATION AGREEMENT WITH GOODLIFE
-
17th August 2023
ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY